Phillip Williams

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Midatech Limited, Monosol Rx, LLC. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip Williams. Retrieved from https://idiyas.com/inventor/phillip-williams-degqjval

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 4)

% Patents Active = 11.1

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 38(Granted Patents)

Location History:

Botley, GB (2014 - 2015)
Oxfordshire, GB (2013 - 2017)
Oxford, GB (2014 - 2020)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2013-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10688125 - Nanoparticles and their use in cancer therapy (2020-06-23),

2. 9598479 - Nanoparticle-peptide compositions (2017-03-21),

3. 9474687 - Combination peptide-nanoparticles and delivery systems incorporating same (2016-10-25),

4. 9352026 - Nanoparticle-insulin and insulin analogue compositions (2016-05-31),

5. 9114082 - Nanoparticle peptide compositions (2015-08-25),

6. 8974826 - Nanoparticle film delivery systems (2015-03-10),

7. 8895023 - Nanoparticles for providing immune responses against infectious agents (2014-11-25),

8. 8790704 - Combination peptide-nanoparticles and delivery systems incorporating same (2014-07-29),

9. 8568781 - Peptide-carrying nanoparticles (2013-10-29),

Title: The Innovative Contributions of Phillip Williams

Introduction

Phillip Williams is a notable inventor based in Oxfordshire, GB, recognized for his significant contributions to the field of nanotechnology and cancer therapy. With a total of nine patents to his name, Williams has made strides in developing innovative solutions aimed at improving treatment methods for various medical conditions.

Latest Patents

Among his latest patents, Williams has developed a nanoparticle designed for use in cancer therapy. This invention features a core made of metal and a corona that includes a variety of ligands. These ligands are covalently linked to the core and include components that are particularly effective in treating skin cancer in mammalian subjects. The invention also outlines methods for administering these nanoparticles, either alone or in conjunction with radiotherapy.

Another significant patent by Williams involves nanoparticle-peptide compositions. This invention provides nanoparticles that facilitate the intracellular delivery of peptides. The nanoparticles consist of a core made of metal or semiconductor atoms, surrounded by ligands that are covalently linked to the core. This innovative approach enhances the effectiveness of peptide delivery, which is crucial for various therapeutic applications.

Career Highlights

Throughout his career, Phillip Williams has worked with several prominent companies, including Midatech Limited and Monosol Rx, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of nanotechnology.

Collaborations

Williams has collaborated with notable individuals in his field, including Thomas William Rademacher and Alexander Mark Schobel. These partnerships have fostered an environment of innovation and have led to the development of advanced technologies in cancer treatment.

Conclusion

Phillip Williams stands out as a pioneering inventor whose work in nanoparticles and cancer therapy has the potential to transform medical treatments. His dedication to innovation and collaboration continues to drive advancements in the field, making him a significant figure in contemporary research.

Profile summary based on public USPTO records.